Chart Events
Performance Outlook
| Previous Close | 0.0075 |
| Open | 0.0078 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0062 - 0.0083 |
| 52 Week Range | 0.0010 - 0.0830 |
| Volume | 26,784,704 |
| Avg. Volume | 68,197,975 |
| Market Cap | 5.099M |
| Beta (5Y Monthly) | 1.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3860 |
| Earnings Date | May 17, 2019 - May 20, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- ACCESSWIRE
ANY LAB TEST NOW(R) Announces Partnership with EVIO, Inc. (OTC: EVIO) to Provide Hemp Oil and Hemp Derived CBD Product Testing
HENDERSON, NV / ACCESSWIRE / November 19, 2020 / ANY LAB TEST NOW®, a leading provider of direct access lab testing established a partnership with EVIO (OTC PINK:EVIO), an ISO accredited testing company to enable CBD manufacturers and retailers to test CBD Products for safety and transparency.
- ACCESSWIRE
EVIO, Inc. Expands CDB Product Stability Studies Internationally
HENDERSON, NV / ACCESSWIRE / October 8, 2020 / EVIO, Inc.
- Business Wire
EVIO Inc. Engages Experienced Cannabis Operator as Strategic Advisor
EVIO Inc. (the "Company" or "EVIO") (OTC:EVIO), one of North America’s most seasoned cannabis testing companies, has retained experienced cannabis operator Chris Boudreau as an strategic consultant. Mr. Boudreau’s experience and deep involvement in the cannabis industry brings meaningful opportunities that EVIO can leverage for repositioning the company to boost marketing, increase sales and improve margins. Mr. Boudreau also brings to the company a wealth of connections and resources needed to develop and implement a new strategic plan that will enable EVIO to return to growth in 2021 and beyond..
